Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)

BACKGROUND: Particularly since the advent of lenalidomide, lower-risk myelodysplastic syndromes (MDS) patients with del(5q) have been the focus of many studies; however, the impact of age on disease characteristics and response to lenalidomide has not been analyzed. METHODS: We assessed the effect o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Hematol Oncol
Glavni autori: Fenaux, Pierre, Giagounidis, Aristoteles, Selleslag, Dominik, Beyne-Rauzy, Odile, Mittelman, Moshe, Muus, Petra, Nimer, Stephen D., Hellström-Lindberg, Eva, Powell, Bayard L., Guerci-Bresler, Agnes, Sekeres, Mikkael A., Deeg, H. Joachim, del Cañizo, Consuelo, Greenberg, Peter L., Shammo, Jamile M., Skikne, Barry, Yu, Xujie, List, Alan F.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485496/
https://ncbi.nlm.nih.gov/pubmed/28651604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0491-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items